G erm cell tumors constitute up to 20% of all mediastinal masses. 1, 2 Their symptoms are commonly caused by compression or invasion of surrounding structures, and patients usually present with weight loss, fatigue, respiratory distress, and py--rexia. The association of mediastinal germ cell tumors with hematological disorders including leukaemias, my--elodysplastic syndrome, malignant histiocytosis and he--mophagocytic syndrome had been documented. 3, 4 We present a patient who had a mediastinal endodermal si--nus tumor (EST) (known also as yolk sac tumor) who developed pancytopenia due to marked hemophago--cytic syndrome.
CASE
A 24-year-old male patient presented with a 3-month history of fever, dry cough and weight loss. On exami--nation the right side of the chest was dull on percus--sion and breath sounds were absent. His chest x-ray and computerized tomography (CT) scan showed a large mediastinal tumor with right-sided pleural effu--sion (Figure 1 /L). Ddimers were significantly increased (1335 mg/L, nor--mal: 0.5 mg/L). Alpha-fetoprotein levels were mark--edly elevated (12 000 ng/mL, normal: 44 ng/L). A CTguided needle biopsy of the mediastinal mass was done after blood and platelet transfusion. The histopathology result showed an endodermal sinus tumor (Figure 2) . Bone marrow biopsy revealed many macrophages with engulfed red blood cells present within their cytoplasm (Figure 3) . One liter of hemorrhagic pleural fluid was drained from the right pleural cavity. A cytological ex--amination was negative for malignant cells. The patient was placed on steroids and a chemotherapy regimen of cisplatin, etoposide and bleomycin. Following the first cycle of chemotherapy his conditioned deteriorated. It was decided to stop further chemotherapy as he was not in condition to withstand a second cycle of chemo--therapy. The patient was referred to palliative care, and he expired one week later.
DISCUSSION
Mediastinal germ cell tumors are rare. However, they are the most common location for primary extragonadal germ cell lesions, representing 10% to 20% of all neo--plasms in this location 1 and up to 15% of anterior me-- diastinal tumors. 2 In a review of 322 cases of primary germ cell tumors of the mediastinum, the distribution of tumor types were 44% teratomas, 37% seminomas, 16% non-seminomatous germ cell tumors including endoder--mal sinus tumors (EST), and 3% combined tumors. 5 There are several reported cases of EST of the medi--astinum, including a short series of ten cases 6 and seven cases 7 as well as a large series of 38 cases from the Armed Forces Institute of Pathology (AFIP). 8 These studies em--phasized the predilection of this tumor to affect young adult males as in the present case, with a mean age of 26 to 30 years, and the lethal outcome of the tumor, par--ticularly when it is unresectable. The aggressive nature of primary non-seminomatous tumors of the mediastinum is clear, with 72% of the patients dead of their tumor 6 to 36 months after diagnosis despite aggressive therapy. 8 The association of mediastinal EST and other non-sem--inomatous germ cells with hematological disorders and malignancies had been documented in several reports. In one large study of 635 patients with extragonadal germ cell tumors, including 341 mediastinal tumors, treated at major hospitals in the USA and Europe, 17 patients were found to have hematological disorders. All of these patients had a mediastinal non-seminomatous germ cell tumor. The hematological conditions include myelodys--plastic syndrome (5 cases), acute megakaryocytic leuke--mia (5 cases), acute myeloblastic leukemia (1 case), acute myelomonocytic leukemia (1 case), acute undifferenti--ated leukemia (2 cases), mast cell leukemia (2 cases) and histiocytosis (1 case). All these patients died within two years after diagnosis of their hematological malignancy with a median survival time of 5 months (range 0-16 months). 3 In another review of patients with mediastinal germ cell tumor who received chemotherapy prior to the development of hematological malignancies, a total of 19 patients with non-seminomatous germ cell tumors, in--cluding 3 patients who had EST component, developed various types of acute myelogenous leukemia. 9 In a third study from the University of Indiana, 16 patients had mediastinal germ cell tumors and hemato--logical neoplasms. All patients had non-seminomatous germ cell tumors, with EST or embryonal carcinoma in combination with teratoma was quite common. The two most common hematological neoplasms in this series were acute megakaryocytic leukemia and malig--nant histiocytosis. 10 This association between medias--tinal non-seminomatous germ cell tumors, particularly EST, prompted Orazi and his colleagues to look into a hypothesis postulating that these leukemic conditions originated from progenitor cells within these tumors that were capable of undergoing hematopoietic differ--entiation. They examined histological tumor material from six patients using immunohistochemical mark--ers for different bone marrow cell lineages. They found identifiable hematological cells within the yolk sac tu--mor component of four patients.
11
A case of unusual association of mediastinal terato--ma with EST and myelomonocytic leukemia associated with Klinefelter syndrome was reported in a 14-yearold male who underwent thoracotomy and biopsy of the mediastinal tumor, but died a week later.
12
In another case, an unusual association of a medi--astinal mixed germ cell tumor containing elements of seminoma, immature teratoma, EST, embryonal carci--noma and angiosarcoma with a histiocytic sarcoma of the spleen occurred in a 15-year-old boy who presented with chest pain. 13 The association of mediastinal EST or other nonseminomatous germ cell tumors with the hemophago--cytic syndrome has been documented in sporadic case reports. This syndrome is synonymous with hemo--phagocytic lymphohistiocytosis, can be of primary or familial with autosomal recessive inheritance, 14 or secondarily associated with infections, 15,16 malignan--cies and rheumatologic disorders. 17 The pathophysi--ology of this syndrome appears to involve the marked activation of lymphocytes and macrophages, with an abnormal expression of perforin, hMunc13-4 (UNC 13D) and syntaxin 11, all cytotoxic granule associated proteins, 18 resulting in a release of cytokines produced by these cells including IFN-gamma, IL-6, IL-10, IL-12, IL-16, IL-18, and TNF-alpha. This can result in organ dysfunction due to organ infiltration and ex--cessive phagocytosis of blood cells and their precur--sors in bone marrow, liver, spleen and other organs. 19 When hemophagocytic syndrome is associated with non-malignant pathology such as viral, bacterial, pro--tozoal, and collagen disorders, it usually resolves once the basic disease is treated. 15 However, when it is as--sociated with malignancy, the prognosis is very poor and the median survival is 3 to 4 months from the onset of disease.
Hemophagocytic syndrome associated with medi--astinal germ cell tumor is very rare. To the best of our knowledge thirteen cases have been reported in the literature to date, including four cases associated with reactive hemophagocytic syndrome while the rest were associated with malignant histiocytosis or histiocytic sarcoma. 4, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Our case is the fifth case of reactive hemophagocytic syndrome associated with mediastinal non-seminoma--tous germ cell tumor that is composed mainly of endo--dermal sinus (yolk sac) tumor. The outcome of these tumors in association with hemophagocytic syndrome is very poor irrespective of metastatic status, and pa--tients survive only for a few months from the onset of disease despite the various treatment modalities in--cluding steroids immunotherapy and chemotherapy. When mediastinal germ cell tumors are not associated with hemophagocytic syndrome, the 5-year survival is 50% with conventional chemotherapy. There are two chemotherapy regimens: conventional alone and high dose chemotherapy (HDCT) with autologus stem cell transplantation, which have been given in many trials. Randomized trials in the United States and Europe using HDCT in patients at poor risk with metastasis, did not show any survival benefit. When non-semino--matous germ cell tumors are not associated with hemo--phagocytic syndrome the 5-year survival is 50% with conventional chemotherapy. 
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